Treatment with T22-PE24-H6 and T22-DITOX-H6 nanotoxins clearly impaired tumor growth in the CXCR4-overexpressing subcutaneous tumors, as tumors from the buffer-treated animals reached bigger volumes compared to their nanotoxin-treated counterparts (Fig. 4B). The gene discussed is CXCR4; the disease is neoplasm.